-

MetLife Announces New $3 Billion Share Repurchase Authorization

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the $475 million remaining under the company’s prior authorization announced in August 2021.

Commenting on the announcement, MetLife President and CEO Michel Khalaf said: “This new share repurchase authorization demonstrates our confidence in MetLife’s financial strength and is consistent with a balanced approach to capital management as we continue to invest in profitable growth and consistently increase our common dividend.”

About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Forward-Looking Statements
The forward-looking statements in this news release, using words such as “consistent,” “continue,” and “demonstrates,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it has no obligation to correct or update any of these statements.

Contacts

For Media:
Meredith Hyland
212-578-9415
Meredith.Hyland@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

MetLife, Inc.

NYSE:MET

Release Summary
MetLife announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock.
Release Versions

Contacts

For Media:
Meredith Hyland
212-578-9415
Meredith.Hyland@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

More News From MetLife, Inc.

MetLife Increases Common Stock Dividend by 4.4%

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a second quarter 2026 common stock dividend of $0.5925 per share, an increase of 4.4% from the first quarter common stock dividend of $0.5675 per share. MetLife has increased its common stock quarterly dividend at an 8.1% compound annual growth rate since 2011. The dividend will be payable on June 9, 2026, to shareholders of record as of May 12, 2026. “We are pleased to increase our com...

Majority of Employers Support Embedding Guaranteed Lifetime Income Options into Workplace Retirement Plans, MetLife Poll Finds

NEW YORK--(BUSINESS WIRE)--Released today, MetLife’s 2026 Lifetime Income Poll finds that defined contribution (DC) plan sponsors increasingly support approaches that help workers convert retirement savings into a dependable income stream. Nine in 10 DC plan sponsors (90%) say the core purpose of a DC plan should be to serve as an income source during retirement, signaling broad employer alignment around lifetime income options in 401(k) plans and strong engagement with the policy conversation...

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.02 percent of MetLife shares of common stock outstanding as of March 31, 2026. Potemkin’s offer price of $44.20 per share is approximately 41.35 percent lower than the $75.36 closing price of MetLife common sto...
Back to Newsroom